Insights into Company

Emami Agrotech ↗

📍 Kolkata, West Bengal, India Active CIN U24233WB2002PLC094530 Food & Beverages
Search companies

Key Metrics of Emami Agrotech

Revenue₹19,962 Cr▲ 18.0% YoYFY 2025-26
EBITDA₹279 Cr▼ 38.8% YoY
Net profit−₹286 Cr▼ 550.6% YoY
Net worth—
Competitors10identified

About Emami Agrotech

Sectors

Food & BeveragesEdible Oil & Refined Oil

Company details

Website
emamiagrotech.com
Registered office
687, Anandapur E.m. Bypass, Kolkata, In-wb, 700107

Operational Areas of Emami Agrotech

Food & Beverages›Edible Oil & Refined Oil

Company summary

Entity details

CINU24233WB2002PLC094530
LEI code335800D1BNHDSS9KUE55
State codeWB
PIN code700107
Current legal nameEMAMI AGROTECH
Classification—
Listing statusUnlisted
Registration no.094530
Company age—
PAN—
CountryIndia
CityKolkata
StateWest Bengal
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code24233
Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
SectorFood & Beverages · Edible Oil & Refined Oil
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 6 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 36 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

ICRA · 05 Oct 2026 ICRA A- Stable outlook · Short term A2+ · Reaffirmed
CARE · 07 Oct 2025 — Other
Change in last 12 monthsNo change
Change since first rating on recordNo changesince Jan 2018
Rating actions120 up · 0 down
Liquidity (ICRA)Adequate

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
05 Oct 2026ICRAReaffirmed A-A2+Stable₹724 Cr View
07 Oct 2025CAREOther ———— View
28 Mar 2025CAREOther ———— View
28 Oct 2024CAREOther ———— View
05 Apr 2024CAREOther ———— View
17 Jul 2023CAREReaffirmed A-A2+Negative₹7,555 Cr View
06 Jan 2023CAREReaffirmed A-A2+Stable₹7,555 Cr View
07 Dec 2021CARERevised A-A2+Stable₹13,906 Cr View
06 Jan 2021CAREReaffirmed A-A2Stable₹13,539 Cr View
08 Jan 2020CAREReaffirmed A-A2Stable₹13,883 Cr View
08 Jan 2019CAREReaffirmed A-A2Stable₹12,257 Cr View
25 Jan 2018CAREReaffirmed A-A2Stable₹5,010 Cr View

Credit strengths (ICRA, Oct 2026)

+ Strong parentage and financial support from Emami Group

EAL enjoys financial support from the Emami Group, which has extended support to various Group companies in the past, including EAL.

+ Strong market position, supported by established brands and wide distribution network

EAL has a strong market position in the edible oil business, leveraging its well-established brands, Emami Healthy and Tasty and Himani Best Choice.

+ Strategic orientation towards expanding the foods business

The edible oil business remains exposed to risks associated with price volatility and regulatory uncertainty, in addition to low profitability.

Credit challenges

− Profitability remains susceptible to high competitive intensity

The industry continues to face intense competition from both large and organised players, as well as from the fragmented, unorganised market.

− Susceptibility of the edible oil business to price, inventory and currency risks

Similar to its peers, EAL’s profitability remains exposed to volatility in the prices of crude and refined edible oil, the risk of inventory losses, currency fluctuations, and potential supply disruptions.

− Moderate financial risk profile

EAL’s performance was subdued in FY2026 due to inventory loss in Q1 FY2026, following the reduction in import duty on crude palm oil to 10% from 20%, a foreign exchange (forex) loss in Q4 FY2026 owing to the INR www.icra.in Sensitivity Label : Public Page |2 depreciation on its structured derivative contracts, and a payout under the amnesty scheme towards an entry tax dispute pending before the Supreme Court.

− Regulatory risks on account of being part of the highly regulated edible oil industry

Indian edible oil refiners have a significant dependence on imports.

Could lead to an upgrade

The ratings may be upgraded if the company achieves greater business diversification, resulting in lower margin volatility and sustained improvement in profitability. This should be accompanied by a reduction in financial leverage and maintenance of comfortable

Could lead to a downgrade

Any sustained weakening of profitability or large debt-funded capex weakening the credit metrics, would pose a pressure on EAL’s ratings. Further, a material change in the Group’s credit profile or lack of committed support could also trigger a downward revision in the ratings.

Agency-reported financials (ICRA, 05 Oct 2026)

MetricFY2025FY2026
Operating income₹16,916 Cr₹19,962 Cr
PAT₹63.40 Cr₹-,285.70 Cr
OPBDIT/OI2.7%1.4%
PAT/OI0.4%-1.4%
Total outside liabilities/Tangible net worth (times)4.20×7.50×
Total debt/OPBDIT (times)2.80×7.60×
Interest coverage (times)1.20×0.60×
Revenue growth (YoY)—18.0%
EBITDA (margin × income)₹457 Cr₹279 Cr
Implied total debt (debt/EBITDA × EBITDA)₹1,279 Cr₹2,124 Cr
Implied interest cost (EBITDA ÷ coverage)₹381 Cr₹466 Cr

Borrowings & rated debt

Rated borrowing limits (latest)₹7,555 Cr
Peak rated limits₹13,906 CrDec 2021 · CARE
Limits raised2 times1 new facility rated
Average remaining tenor3.4 years
Next maturity31 Mar 2030₹324 Cr

Rated limits over time

Facility mix

Maturity ladder

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long Term Bank FacilitiesWorking capital & bank lines—₹1,050 Cr— A- (Negative)ReaffirmedCARE
Short Term Bank FacilitiesWorking capital & bank lines—₹6,505 Cr— A2+RevisedCARE

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
—Term loans FY FYTerm loans— 31 Mar 202431 Mar 2030 ₹324 CrA- Outstanding

CARE ratings on record (checked 24 Oct 2026)

InstrumentAmountRating
Bank Guarantee₹80.0 CrCARE A2+
Cash Credit—Withdrawn
Forward Contract—Withdrawn
Letter of credit₹5,470 CrCARE A2+
Long Term—Withdrawn
Term Loan₹583 CrCARE A-; Stable

Lenders

Fund-based - LTTerm LoanBandhan Bank Ltd.
Fund-based - LTTerm LoanIDFC First Bank Ltd.
Fund-based - LTTerm LoanIndian Bank
Fund-based - LTTerm LoanIndusInd Bank Ltd.
Fund-based - LTTerm LoanKarnataka Bank Ltd.
Fund-based - LTTerm LoanPunjab & Sind Bank
Fund-based - LTTerm LoanPunjab National Bank
Fund-based - LTTerm LoanRBL Bank Limited
Fund-based - LTTerm LoanUCO Bank
Non-fund-based - STBank GuaranteeBank of Baroda
Non-fund-based - STBank GuaranteeIndian Bank
Non-fund-based - STBank GuaranteeState Bank of India
Non-fund-based - STBank GuaranteeUCO Bank
Non-fund-based - STLetter of creditAxis Bank Ltd.
Non-fund-based - STLetter of creditBank of Bahrain and Kuwait B.S.C
Non-fund-based - STLetter of creditBank of Baroda
Non-fund-based - STLetter of creditCentral Bank of India
Non-fund-based - STLetter of creditICICI Bank Ltd.
Non-fund-based - STLetter of creditIDBI Bank Ltd.
Non-fund-based - STLetter of creditIDFC First Bank Ltd.
Non-fund-based - STLetter of creditIndian Bank
Non-fund-based - STLetter of creditIndusInd Bank Ltd.
Non-fund-based - STLetter of creditKarnataka Bank Ltd.
Non-fund-based - STLetter of creditPunjab & Sind Bank
Non-fund-based - STLetter of creditPunjab National Bank
Non-fund-based - STLetter of creditRBL Bank Limited
Non-fund-based - STLetter of creditSBM Bank (India) Ltd.
Non-fund-based - STLetter of creditState Bank of India
Non-fund-based - STLetter of creditUCO Bank
Non-fund-based - STLetter of creditUnion Bank of India
Non-fund-based - STLetter of creditYes Bank Ltd.

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStretchedAgency: Adequate
DirectionStableAgency outlook: Stable
ICRA rating · Oct 2026A-1 notch above indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)64%
Information on file67% · missing: Annual results history (3+ years), Auditor details, Shareholding pattern

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 64% (Mostly stable) · scorecard until enough rating history is collected
Rated limits₹724 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage0.60×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 64% chance the next rating action is stable or better
  • Current rating A- (investment grade)
  • Interest coverage 0.6×

What happened, step by step

Capex funded with bank debt
  1. Oct 2026 — Project / plant of ₹200 cr
  2. Oct 2026 — Term debt tied up

“While no major project capex is envisaged in the current fiscal, the company intends to set up a compressed biogas (CBG) plant in Madurai at an estimated cost of around Rs. 200 crore.”

Rated limits by facility

Timeline

05 Oct 2026 ICRA reaffirmed: A- (Stable)Rated limits ₹724 cr ICRA rationale
05 Oct 2026 New borrowing arranged (term loans)
From the report

October 05, 2026 Emami Agrotech Limited: Long-term rating reaffirmed; short-term rating assigned; rated amount enhanced Summary of rating action Previous rated amount Current rated amount Financial sector Instrument* Rating action # (Rs. crore) (Rs. crore) regulator Long-term – Fund-based – [ICRA]A- (Stable); reaffirmed and 34.00 324.00 RBI Term loans assigned for enhanced amount Short-term – Fund-based - 0.00 400.00 [ICRA]A2+; assigned RBI Others Total 34.00 724.00 *Instrument details are provided in Annexure I #SEBI’s grievance redressal/dispute resolution and SEBI investor protection mechan

ICRA rationale
05 Oct 2026 Capex / project: ₹200 cr
From the report

While no major project capex is envisaged in the current fiscal, the company intends to set up a compressed biogas (CBG) plant in Madurai at an estimated cost of around Rs. 200 crore.

ICRA rationale
05 Oct 2026 ₹938 cr raised through optionally convertible debentures
From the report

For EAL, this manifested in an equity infusion of Rs. 938 crore in the form of zero-coupon optionally convertible debentures in FY2022.

ICRA rationale
05 Oct 2026 Cash & liquid funds ₹380 cr
From the report

Liquidity position: Adequate EAL’s liquidity is Adequate, supported by free cash and bank balance of Rs. 380 crore as on March 31, 2026.

ICRA rationale
05 Oct 2026 Cash & liquid funds ₹2,300 cr
From the report

It also frequently utilises additional limits at a 100% margin money requirement, leading to a high encumbered cash balance of around Rs. 2,300 crore as on March 31, 2026.

ICRA rationale
07 Oct 2025 CARE other: — CARE rationale
07 Oct 2025 ₹30 cr raised through equity
From the report

In November 2022, the company raised equity of ₹30 crore from an investor.

CARE rationale
07 Oct 2025 Cash & liquid funds ₹214 cr
From the report

Liquidity: Adequate EAL had total cash and bank balance of ₹214 crore as on March 31, 2025.

CARE rationale
07 Oct 2025 Cash & liquid funds ₹279 cr
From the report

The company earned adjusted gross cash accruals of ₹279 crore in FY25.

CARE rationale
07 Oct 2025 Debt repayments due in FY26: ₹185 cr
From the report

Scheduled term debt repayment obligation of ~₹185 crore in FY26 is being met from cash accruals and available cash balance.

CARE rationale
28 Mar 2025 CARE other: — CARE rationale
28 Mar 2025 Capex / project: ₹60 cr
From the report

EAL has set up a 400 TPD solvent extraction plant and 50 TPD refinery unit at Jaipur, Rajasthan, commissioned in April 2024 within the budgeted cost of ₹60 crore, to manufacture de-oiled cake and solvent mustard oil by way of forward integration to enable the company to process the oil cake, which is produced by the existing Jaipur unit operations.

CARE rationale
28 Mar 2025 Capex / project: ₹50 cr
From the report

EAL has also set up a bio- diesel plant at Krishnapatnam unit, commissioned in April 2024 within the budgeted cost of ₹50 crore, as maintained by the management.

CARE rationale
28 Mar 2025 New borrowing arranged: ₹70 cr (term loans)
From the report

EAL is increasing the capacity of its Bio-diesel plant at Haldia, West Bengal, by 300 TPD, at an estimated cost of ₹70 crore, which is proposed to be funded by promoter contribution of ₹20 crore and term loan of ₹50 crore, which has been tied up.

CARE rationale
28 Mar 2025 Capex / project: ₹70 cr
From the report

EAL is increasing the capacity of its Bio-diesel plant at Haldia, West Bengal, by 300 TPD, at an estimated cost of ₹70 crore, which is proposed to be funded by promoter contribution of ₹20 crore and term loan of ₹50 crore, which has been tied up.

CARE rationale
28 Mar 2025 Cash & liquid funds ₹179 cr
From the report

Liquidity: Adequate EAL had total cash and bank balance of ₹179 crore as on December 31, 2024.

CARE rationale
28 Mar 2025 Cash & liquid funds ₹349 cr
From the report

The company earned adjusted gross cash accruals (GCA) of ₹349 crore in 9MFY25 (standalone).

CARE rationale
28 Mar 2025 Debt repayments due in FY25: ₹213 cr
From the report

The company has scheduled term debt repayment obligation of ~₹213 crore in FY25 which is being met out of cash accruals and available cash balance.

CARE rationale
28 Mar 2025 Cash & liquid funds ₹504 cr
From the report

With subdued operating performance and higher finance cost (₹397 crore in FY24), the company incurred cash loss of ~₹504 crore in FY24, which was funded out of liquidation of inventory and increased borrowings.

CARE rationale
28 Mar 2025 ₹30 cr raised through equity
From the report

In November 2022, the company raised equity of ₹30 crore from an investor.

CARE rationale
28 Oct 2024 CARE other: — CARE rationale
28 Oct 2024 Capex / project: ₹60 cr
From the report

The project was commissioned in April 2024 within the budgeted cost of ₹60 crore, as maintained by the management.

CARE rationale
28 Oct 2024 Cash & liquid funds ₹1,600 cr
From the report

Liquidity: Adequate EAL had total cash and bank balance of ₹1,600 crore (including margin money of ₹1,408 crore) as on March 31, 2024.

CARE rationale
28 Oct 2024 Cash & liquid funds ₹504 cr
From the report

The company incurred cash loss of ₹504 crore (adjusted) in FY24, which was funded out of liquidation of inventory and increase in borrowings.

CARE rationale
28 Oct 2024 Debt repayments due in FY24: ₹205 cr
From the report

The company had scheduled term debt repayment obligation of around ₹205 crore in FY24 which was paid out of cashflow from operations.

CARE rationale
28 Oct 2024 ₹30 cr raised through equity
From the report

Further, in November 2022, the company raised equity of ₹30 crore from an investor.

CARE rationale
05 Apr 2024 CARE other: — CARE rationale
05 Apr 2024 Capex / project: ₹60 cr
From the report

The project is in the process of commissioning in April 2024 within the budgeted cost of ₹60 crore, as maintained by the management.

CARE rationale
05 Apr 2024 Cash & liquid funds ₹1,950 cr
From the report

Liquidity: Adequate EAL had total cash and bank balance of ₹1,950 crore (including margin money of ₹1,845 crore) as on December 31, 2023.

CARE rationale
05 Apr 2024 Cash & liquid funds ₹514 cr
From the report

The company incurred cash loss of ₹514 crore in 9MFY24, which was funded out of liquidation of inventoryand increase in borrowings.

CARE rationale
05 Apr 2024 Debt repayments due in FY24: ₹205 cr
From the report

The company had scheduled term debt repayment obligation of around ₹205 crore in FY24 which was paid out of cashflow from operations.

CARE rationale
05 Apr 2024 ₹30 cr raised through equity
From the report

Further, in November 2022, the company raised equity of ₹30 crore from an investor.

CARE rationale
17 Jul 2023 CARE reaffirmed: A- (Negative)Rated limits ₹7,554.59 cr CARE rationale
17 Jul 2023 ₹30 cr raised through equity
From the report

In November 2022, the company had raised equity of ₹30 crore from an investor.

CARE rationale
17 Jul 2023 Capex / project: ₹60 cr
From the report

The project is in the process of commissioning in July 2023 within the budgeted cost of ₹60 crore, as maintained by the management.

CARE rationale
17 Jul 2023 Cash & liquid funds ₹1,892 cr
From the report

Liquidity: Adequate EAL had total cash and bank balance of ₹1,892 crore (including margin money of ₹1,693 crore) as on March 31, 2023.

CARE rationale
17 Jul 2023 Cash & liquid funds ₹370 cr
From the report

Press Release company incurred cash loss of ₹370 crore in FY23 (Provisional) which was funded out of liquidation of inventory, collection of debtors and out of available cash balance.

CARE rationale
17 Jul 2023 Debt repayments due in FY24: ₹200 cr
From the report

The company has scheduled term debt repayment obligation of around ₹200 crore in FY24 against which the company is expected to generate adequate cash accruals .

CARE rationale
17 Jul 2023 New borrowing arranged: ₹467 cr (term loans)
From the report

It availed short term loan of ₹467 crore in Q1FY24 to support its liquidity.

CARE rationale
06 Jan 2023 CARE reaffirmed: A- (Stable)Rated limits ₹7,554.59 cr CARE rationale
06 Jan 2023 ₹150 cr raised through equity
From the report

Furthermore, ₹150 crore was infused as equity in FY21 to fund EAL’s onward investment in its overseas subsidiary.

CARE rationale
06 Jan 2023 ₹30 cr raised through equity
From the report

In November 2022, the company raised equity of ₹30 crore from an investor.

CARE rationale
06 Jan 2023 Capex / project: ₹72.84 cr
From the report

In view of the increasing sales and better margins, the company has set up a 60 TPD spice grinding and packaging unit at Jaipur, Rajasthan which started operations in June 2022 at a project cost of ₹72.84 crore.

CARE rationale
06 Jan 2023 Cash & liquid funds ₹2,039 cr
From the report

Liquidity: Adequate EAL had total cash and bank balance of ₹2,039 crore (including margin money of ₹1,742 crore) as on March 31, 2022.

CARE rationale
06 Jan 2023 Debt repayments due in FY23: ₹196.53 cr
From the report

The company has scheduled repayment obligation of ₹196.53 crore in FY23.

CARE rationale
06 Jan 2023 Cash & liquid funds ₹296.66 cr
From the report

Though the cash accruals in FY23 are not likely to be sufficient to meet its term debt repayment obligations, it had free cash and cash equivalents of ₹296.66 crore as on March 31, 2022.

CARE rationale
06 Jan 2023 New borrowing arranged: ₹20 cr (term loans)
From the report

It has already tied up the debt component for funding the ongoing solvent extraction project and the commitment from internal accruals for capex stands limited at around ₹20 crore in FY23 and ₹5 crore in FY24.

CARE rationale
07 Dec 2021 CARE revised: A- (Stable)Rated limits ₹13,906.08 cr CARE rationale
07 Dec 2021 ₹57 cr raised through unsecured loans
From the report

The promoters have demonstrated continuous support towards fund requirement of EAL and have funded around Rs.938 crore in the form of unsecured loans as on March 31, 2021, out of which Rs.57 crore was infused in FY21.

CARE rationale
07 Dec 2021 ₹150 cr raised through equity
From the report

Furthermore, Rs.150 crore was infused as equity in FY21 to fund its onward investment in its overseas subsidiary. 1 Complete definitions of the ratings assigned are available at www.careratings.com and in other CARE publications. 1 CARE Ratings Limited Press Release The promoters of the group, Mr R S Agarwal and Mr R S Goenka are professionals with an extensive business experience.

CARE rationale
07 Dec 2021 Capex / project: ₹73 cr
From the report

In view of the increasing sales and better margins, the company is proposing to set up 60 TPD spice grinding and packaging unit in Jaipur, Rajasthan at a cost of around Rs.73 crore which is expected to start operations by April 2022.

CARE rationale
07 Dec 2021 ₹881 cr raised through unsecured loans
From the report

The promoters have also infused significant amount of unsecured loans out of which Rs.881 crore is subordinated to bank debt.

CARE rationale
07 Dec 2021 Debt repayments due in FY22: ₹181 cr
From the report

Liquidity: Adequate EAL is expected to earn adequate cash accruals to meet its term debt repayment obligation of about Rs.181 crore in FY22.

CARE rationale
07 Dec 2021 Cash & liquid funds ₹210 cr
From the report

The company had free cash balance of Rs.210 crore as on March 31, 2021.

CARE rationale
06 Jan 2021 CARE reaffirmed: A- (Stable)Rated limits ₹13,538.92 cr CARE rationale
06 Jan 2021 ₹121 cr raised through unsecured loans
From the report

In FY20, the promoters infused Rs.121 crore as unsecured loans.

CARE rationale
06 Jan 2021 Capex / project: ₹545 cr
From the report

Project Implementation Risk EAL is in the process of setting up a greenfield project of 3,000 TPD edible oil refinery in Kandala, Gujarat at an estimated cost of Rs.545 crores, to be funded through promoters’ contribution of Rs.160 crores and a term loan of Rs.385 crores.

CARE rationale
06 Jan 2021 Capex / project: ₹73 cr
From the report

In view of diversify its product profile and improve its profitability, EAL is setting up a 60 TPD Spice grinding and packaging unit in Jaipur at an estimated cost of Rs.73 crores, to be funded through promoters’ contribution of Rs.23 crores and a term loan of Rs 50 crores.

CARE rationale
06 Jan 2021 Cash & liquid funds ₹722 cr
From the report

The free cash and bank balance (excluding Margin money) stood at Rs.722 crores as on Mar’20.

CARE rationale
06 Jan 2021 Average working-capital utilisation 84%
From the report

Average utilisation levels for the past 12 months ending Nov ’20 stands at ~84% for non-fund based limits.

CARE rationale
06 Jan 2021 Debt repayments due in FY21: ₹122 cr
From the report

The company has a scheduled repayment obligation of around Rs.122 crores in FY21 and cash flows are expected to be sufficient to meet the same.

CARE rationale
08 Jan 2020 CARE reaffirmed: A- (Stable)Rated limits ₹13,883.12 cr CARE rationale
08 Jan 2020 Cash & liquid funds ₹280 cr
From the report

Decline in free cash & liquid investment below Rs.280cr on a sustained basis. 3.

CARE rationale
08 Jan 2020 ₹281 cr raised through unsecured loans
From the report

In FY19, the promoters infused Rs. 281.00 crores as unsecured loans.

CARE rationale
08 Jan 2020 Capex / project: ₹300 cr
From the report

Project Implementation risk The Company is in the process of expanding its existing facility at Haldia by way of setting up 2,000 TPD refining plant at Haldia at capital cost of Rs. 300 crore to produce refined edible oil.

CARE rationale
08 Jan 2020 Capex / project: ₹545 cr
From the report

EAL is also setting up a Greenfield project of 3,000 TPD edible oil refinery in Kandala, Gujarat at an estimated cost of Rs. 545 crores, to be funded through promoters’ contribution of Rs. 160 crores and a term loan of Rs. 385 crores.

CARE rationale
08 Jan 2020 Cash & liquid funds ₹2,871 cr
From the report

Liquidity: Adequate EAL has cash and bank balance (including margin money) amounting to Rs. 2,871 crores as on March 31, 2019.

CARE rationale
08 Jan 2020 Cash & liquid funds ₹383.93 cr
From the report

The cash and bank balance (excluding margin money) stood at Rs.383.93 crores as on March 31, 2019.

CARE rationale
08 Jan 2020 Debt repayments due: ₹297 cr
From the report

In FY20, EAL has repayment obligation of Rs. 297.00 crs and it has paid around Rs 198 crs till September’19.

CARE rationale
08 Jan 2019 CARE reaffirmed: A- (Stable)Rated limits ₹12,257.28 cr CARE rationale
08 Jan 2019 ₹68.5 cr raised through unsecured loans
From the report

In FY18, the promoters infused Rs.68.5 crore as unsecured loans.

CARE rationale
08 Jan 2019 Cash & liquid funds ₹2,840 cr
From the report

EAL has significant cash and bank balance (including margin money) amounting to Rs.2,840 crore as on March 31, 2018.

CARE rationale
08 Jan 2019 Cash & liquid funds ₹313 cr
From the report

The cash and bank balance (excluding margin money) stood at Rs.313 crore as on March 31, 2018.

CARE rationale
08 Jan 2019 ₹150 cr raised through term loans
From the report

Moderate capital structure and debt coverage indicators The increase in term loan for the new projects along with the issue of new debentures amounting to Rs.150 crore led to increase in the overall debt level.

CARE rationale
08 Jan 2019 Capex / project: ₹125 cr
From the report

Project stabilisation risk The company has expanded its existing facility at Haldia by way of setting up 1000 TPD pretreatment & 750 TPD fractionation plant at Haldia at capital cost of Rs.125 crore to produce RPO and also setting up a captive co-generation power plant (7.5 MW) at an estimated cost of Rs.63 crore.

CARE rationale
08 Jan 2019 Capex / project: ₹90 cr
From the report

The company is setting up 400 TPD preparatory Section, 300 TPD Solvent Extraction Unit and 25 TPD Edible oil Refinery in Rajasthan to produce Refined Mustard Oil at an estimated cost of Rs.90 crore, to be funded through promoters’ contribution /internal accruals of Rs.27 crore and term loan of Rs.63 crore.

CARE rationale
25 Jan 2018 CARE reaffirmed: A- (Stable)Rated limits ₹5,010.2 cr CARE rationale
25 Jan 2018 ₹73.1 cr raised through unsecured loans
From the report

In FY17, the promoters infused Rs.73.1 crore as unsecured loans.

CARE rationale
25 Jan 2018 Cash & liquid funds ₹3,070.69 cr
From the report

However, EAL has significant cash and bank balance (including margin money) of Rs.3,070.69 crore as on March 31, 2017 vis-à-vis Rs.1,584.3 crore as on March 31, 2016.

CARE rationale
25 Jan 2018 Capex / project: ₹90 cr
From the report

The company is setting up 400 TPD preparatory Section, 300 TPD Solvent Extraction Unit and 25 TPD Edible oil Refinery in Rajasthan to produce Refined Mustard Oil at an estimated cost of Rs.90 crore, to be funded through promoters’ contribution /internal accruals of Rs.27 crore and term loan of Rs.63 crore.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered office687, ANANDAPUR E.M. BYPASS, Kolkata, IN-WB, 700107
GSTIN—
Email—
Websitehttps://www.emamiagrotech.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Emami Agrotech

Competitors10identified
Locations4most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Gokul Agro Resources Edible Oil & Refined Oil · Food & Beverages gokulagro.com — Ahmedabad, India
Marico Edible Oil & Refined Oil · Food & Beverages marico.com — Mumbai, India
Raj Oil Mills Limited Edible Oil & Refined Oil · Food & Beverages — — Mumbai, India
Agro Tech Foods Edible Oil & Refined Oil · Food & Beverages agrotechfoods.com — India
Srinivasa Oil Mill Edible Oil & Refined Oil · Food & Beverages — — India
Ajanta Soya Limited Edible Oil & Refined Oil · Food & Beverages — — Bhiwadi, Rajasthan, India
Shri Durga Oil Mill Edible Oil & Refined Oil · Food & Beverages — — Uttarakhand, India
Shri Ram Solvent Extractions Private Limited Edible Oil & Refined Oil · Food & Beverages — — Jaspur, India
Sat Sahib Oil Mills Private Limited Edible Oil & Refined Oil · Food & Beverages — — Ludhiana, Punjab, India
Shree Mahavir Oil Mills Edible Oil & Refined Oil · Food & Beverages — — Punjab, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Edible oils

Filings

No filings on record yet.